Patent intelligence · US
US 6245752
Compositions and methods for tolerization in immune complex-mediated disease progression
Compositions and methods for tolerization in immune complex-mediated disease progression
Patent details — US 6245752
- Jurisdiction
- US
- Status
- expired
- Grant date
- Jun 12, 2001
- Expiration
- Jun 7, 2021
- Applicant
- BioCrystal, Ltd.
- Claims
- 23
- CPC classes
- A61K, A61K2039/6093, A61K38/00, A61K39/001169
Quick answer
US 6245752 (Compositions and methods for tolerization in immune complex-mediated disease progression) is held by BioCrystal, Ltd.. Status: expired. Granted Jun 12, 2001. Expires Jun 7, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BioCrystal, Ltd.
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K2039/6093, A61K38/00, A61K39/001169, A61K39/385, A61K47/56
More from BioCrystal, Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12344585
Crystalline salts of a plasma kallikrein inhibitor
granted -
US 12162838
Human plasma kallikrein inhibitors
granted -
US 12121503
Antiviral treatments
granted -
US 12116346
Human plasma kallikrein inhibitors
granted -
US 12054492
Imidazole-containing inhibitors of ALK2 kinase
granted -
US 12043610
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11975003
Methods and compositions for treatment of Zika virus infection
granted -
US 11866418
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted
Frequently asked questions
What is US patent 6245752?
US 6245752 (Compositions and methods for tolerization in immune complex-mediated disease progression) is held by BioCrystal, Ltd.. Status: expired. Granted Jun 12, 2001. Expires Jun 7, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6245752?
BioCrystal, Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 72 pharmaceutical patents for this assignee.
When does US 6245752 expire?
Our index shows an expiration date of Jun 7, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.